Biohaven Pharmaceutical H...
36.19
0.62 (1.74%)
At close: Jan 15, 2025, 1:55 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -408.17M -570.28M -213.80M -118.67M -528.80M -240.92M -127.19M
Depreciation & Amortization 6.91M 1.39M 1.39M 72.00K n/a n/a n/a
Stock-Based Compensation 28.79M 193.56M 65.64M 29.50M 54.97M 16.93M 13.24M
Other Working Capital 19.74M -34.53M 212.90M 166.83M -3.32M -5.39M -3.98M
Other Non-Cash Items 16.13M 106.25M 4.52M 4.16M 93.18M 21.47M 15.16M
Deferred Income Tax n/a n/a -5.26M n/a n/a n/a n/a
Change in Working Capital 24.61M -28.60M 1.66M 8.98M 3.32M 5.39M 3.98M
Operating Cash Flow -331.73M -297.69M -145.84M -75.96M -377.33M -197.14M -94.81M
Capital Expenditures -3.05M -41.07M -938.00K -2.70M -2.53M -4.17M -541.00K
Acquisitions n/a -35.00M 1.88M 267.51M n/a n/a n/a
Purchase of Investments -194.12M -263.72M -193.29M -319.39M n/a -6.38M -6.63M
Sales Maturities Of Investments 327.00M n/a 221.56M 94.98M n/a n/a n/a
Other Investing Acitivies n/a -4.00M -28.27M -43.10M -1.25M n/a 127.00K
Investing Cash Flow 129.83M -304.79M 944.00K -2.70M -3.78M -10.54M -7.04M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -31.32M 483.79M 138.45M 152.24M 434.59M 340.46M 209.76M
Financial Cash Flow 211.91M 767.60M 138.45M 152.24M 434.59M 340.46M 209.76M
Net Cash Flow 9.52M 165.55M -6.45M 73.59M 53.48M 132.78M 107.90M
Free Cash Flow -334.77M -338.76M -146.78M -78.65M -379.87M -201.31M -95.36M

Create Price Alert on BHVN

Your price alert will notify you when the stock price is above 36.19.

Add to Watchlist